Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne K DeGorter

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Hepatology (Baltimore, Md.)|September 30, 2009
Hepatic drug transporters, old and new: pharmacogenomics, drug response, and clinical relevanceMarianne K DeGorter, Richard B Kim
The Canadian Journal of Cardiology|March 8, 2013
Efficacy and plasma drug concentrations with nondaily dosing of rosuvastatinAlyse S Goldberg, Marianne K DeGorter, Matthew R Ban, et al.
Biochemical and Biophysical Research Communications|November 6, 2007
Molecular modeling of the human multidrug resistance protein 1 (MRP1/ABCC1)Marianne K DeGorter, Gwenaëlle Conseil, Roger G Deeley, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 9, 2008
Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3)Caroline E Grant, Mian Gao, Marianne K DeGorter, et al.
Molecular Pharmaceutics|February 23, 2012
Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificityMarianne K DeGorter, Richard H Ho, Brenda F Leake, et al.
Science (New York, N.Y.)|March 17, 2022
Multiple causal variants underlie genetic associations in humansNathan S Abell, Marianne K DeGorter, Michael J Gloudemans, et al.
The Canadian Journal of Cardiology|November 5, 2013
Incremental lowering of low-density lipoprotein cholesterol with ezetimibe 20 mg vs 10 mg daily in patients receiving concomitant statin therapyAhmed Ziada, Ute I Schwarz, Marianne K DeGorter, et al.
The AAPS Journal|January 6, 2021
Mouse NTCP-Mediated Rosuvastatin Uptake In Vitro and in Slc10a1-Deficient MiceLaura E Russell, Marianne K DeGorter, Richard H Ho, et al.
Digestive Diseases and Sciences|July 11, 2015
Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel DiseaseAze Wilson, Wendy A Teft, Bridget L Morse, et al.
Digestive Diseases and Sciences|August 3, 2015
Erratum to: Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel DiseaseAze Wilson, Wendy A Teft, Bridget L Morse, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Hepatology (Baltimore, Md.)|September 30, 2009
Hepatic drug transporters, old and new: pharmacogenomics, drug response, and clinical relevanceMarianne K DeGorter, Richard B Kim
The Canadian Journal of Cardiology|March 8, 2013
Efficacy and plasma drug concentrations with nondaily dosing of rosuvastatinAlyse S Goldberg, Marianne K DeGorter, Matthew R Ban, et al.
Biochemical and Biophysical Research Communications|November 6, 2007
Molecular modeling of the human multidrug resistance protein 1 (MRP1/ABCC1)Marianne K DeGorter, Gwenaëlle Conseil, Roger G Deeley, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 9, 2008
Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3)Caroline E Grant, Mian Gao, Marianne K DeGorter, et al.
Molecular Pharmaceutics|February 23, 2012
Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificityMarianne K DeGorter, Richard H Ho, Brenda F Leake, et al.
Science (New York, N.Y.)|March 17, 2022
Multiple causal variants underlie genetic associations in humansNathan S Abell, Marianne K DeGorter, Michael J Gloudemans, et al.
The Canadian Journal of Cardiology|November 5, 2013
Incremental lowering of low-density lipoprotein cholesterol with ezetimibe 20 mg vs 10 mg daily in patients receiving concomitant statin therapyAhmed Ziada, Ute I Schwarz, Marianne K DeGorter, et al.
The AAPS Journal|January 6, 2021
Mouse NTCP-Mediated Rosuvastatin Uptake In Vitro and in Slc10a1-Deficient MiceLaura E Russell, Marianne K DeGorter, Richard H Ho, et al.
Digestive Diseases and Sciences|July 11, 2015
Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel DiseaseAze Wilson, Wendy A Teft, Bridget L Morse, et al.
Digestive Diseases and Sciences|August 3, 2015
Erratum to: Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel DiseaseAze Wilson, Wendy A Teft, Bridget L Morse, et al.
Pageof 2